About

Publications While At HealthPartners

Highlights

selected publications

Journal Article

Enhancing the interpretation of real-world quality of life in patients with HR+/HER2- advanced breast cancer enrolled in the POLARIS study. 

The oncologist. 2025

Real-world effectiveness of palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer: final results from the POLARIS trial. 

The oncologist. 2025

Real-world effectiveness of palbociclib plus hormone treatment and its impact on patient quality of life: a plain language summary of findings from POLARIS. 

Future Oncology (London, England). 2025

Real-world quality-of-life of patients with HR+/HER2- advanced breast cancer treated with palbociclib plus endocrine therapy: EORTC QLQ-C30 results from POLARIS. 

Breast Cancer Research and Treatment. 2025

Relationship of prior anticancer treatments with palbociclib clinical outcomes in patients with HR(+)/HER2(-) advanced breast cancer in real-world settings. 

Targeted Oncology. 2025

Anthracyclines in early breast cancer: the ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). 

Journal of Clinical Oncology. 2017

Contact

full name

J. L. Blum

Quick Info

Publications

Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Co-author network

Map of science